Literature DB >> 2528955

NH2-terminal amino acid sequence of rabbit hepatopoietin A, a heparin-binding polypeptide growth factor for hepatocytes.

R Zarnegar1, S Muga, J Enghild, G Michalopoulos.   

Abstract

Hepatopoietin A (HPTA) is an acidic heparin-binding polypeptide growth factor for hepatocytes with properties distinct from other known heparin-binding growth factors. HPTA is a heterodimer consisting of a heavy and a light polypeptide chain with Mr of 70,000 and 35,000 respectively. HPTA is a complete mitogen for hepatocytes in that it stimulates DNA synthesis in hepatocytes maintained in serum-free medium. Its complete purification from rabbit serum or human plasma was reported by us elsewhere (R. Zarnegar and G. Michalopoulos, 1989). In the present communication we report the N-terminal amino acid sequence of the HPTA light chain up to 24 residues (VVNGKPTRTNVGRMVSLKYRNKHI) and show that this sequence is unique and not related to any other proteins or growth factors based on computer search analysis. We have also raised antiserum against a synthetic peptide corresponding to the sequence of N-terminal amino acids residues 1 to 24, which recognizes the whole HPTA molecule. This antiserum as well as oligonucleotide probes corresponding to the N-terminal amino acid sequence of HPTA can be used as probes to identify tissue(s) of origin of this growth factor and assist in molecular cloning of its gene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2528955     DOI: 10.1016/0006-291x(89)91130-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Mitogens and hepatocyte growth control in vivo and in vitro.

Authors:  K S Koch; X P Lu; D A Brenner; G H Fey; A Martinez-Conde; H L Leffert
Journal:  In Vitro Cell Dev Biol       Date:  1990-11

2.  Growth factors and the liver.

Authors:  A C Selden; H J Hodgson
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

3.  Down-regulation of CMTM8 induces epithelial-to-mesenchymal transition-like changes via c-MET/extracellular signal-regulated kinase (ERK) signaling.

Authors:  Wenjuan Zhang; Michelle C Mendoza; Xiaolei Pei; Didem Ilter; Sarah J Mahoney; Yingmei Zhang; Dalong Ma; John Blenis; Ying Wang
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

4.  Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues.

Authors:  K Tashiro; M Hagiya; T Nishizawa; T Seki; M Shimonishi; S Shimizu; T Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

5.  Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes.

Authors:  R Zarnegar; S Muga; R Rahija; G Michalopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

6.  Expression of HGF mRNA in human rejecting kidney as evidenced by in situ hybridization.

Authors:  K Yamaguchi; M A Nalesnik; G K Michalopoulos
Journal:  Urol Res       Date:  1996

Review 7.  Protooncogenes and growth factors associated with normal and abnormal liver growth.

Authors:  N Fausto
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

8.  Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes.

Authors:  A J Strain; T Ismail; H Tsubouchi; N Arakaki; T Hishida; N Kitamura; Y Daikuhara; P McMaster
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

9.  Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference.

Authors:  Shirish Paranjpe; William C Bowen; Aaron W Bell; Kari Nejak-Bowen; Jian-Hua Luo; George K Michalopoulos
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

10.  ELISA for F-TCF (human hepatocyte growth factor/hHGF)/fibroblast-derived tumor cytotoxic factor antigen employing monoclonal antibodies and its application to patients with liver diseases.

Authors:  N Shima; K Higashio; H Ogaki; K Okabe
Journal:  Gastroenterol Jpn       Date:  1991-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.